NASDAQ : NEPH
Nephros, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 3.17 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 34.43M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 35.19M |
| Enterprise Value | 31.36M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 10.86M |
| Shares Outstanding | 10.86M |
| Shares Change (YoY) | +4.21% |
| Shares Change (QoQ) | +1.11% |
| Owned by Insiders (%) | 17.78% |
| Owned by Institutions (%) | 17.87% |
| Float | 8.93M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 20.25 |
| Forward PE | 17.05 |
| PS Ratio | 1.66 |
| Forward PS | 1.45 |
| PB Ratio | 2.88 |
| P/TBV Ratio | 3.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 17.63 |
| EV / Sales | 1.48 |
| EV / EBITDA | 17.31 |
| EV / EBIT | 18.64 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.07 |
| Quick Ratio | 2.63 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.39 |
| Debt / FCF | n/a |
| Interest Coverage | 1,642.00 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 16.10% |
| Return on Assets (ROA) | 7.33% |
| Return on Invested Capital (ROIC) | 20.60% |
| Return on Capital Employed (ROCE) | 13.21% |
| Weighted Average Cost of Capital (WACC) | 13.56% |
| Revenue Per Employee | $575,611 |
| Profits Per Employee | $48,222 |
| Employee Count | 36 |
| Asset Turnover | 1.48 |
| Inventory Turnover | 2.37 |
Taxes
| Measure | Value |
|---|
| Income Tax | 16,000 |
| Effective Tax Rate | 0.91% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.75 |
| 52-Week Price Change | -43.16% |
| 50-Day Moving Average | 3.89 |
| 200-Day Moving Average | 3.66 |
| Relative Strength Index (RSI) | 39.36 |
| Average Volume (20 Days) | 59,226 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 15,442 |
| Short Previous Month | 25,302 |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.17% |
| Short Ratio (days to cover) | 0.43 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 20.72M |
| Gross Profit | 12.70M |
| Operating Income | 1.64M |
| Pretax Income | 1.75M |
| Net Income | 1.74M |
| EBITDA | 1.77M |
| EBIT | 1.64M |
| Earnings Per Share (EPS) | $0.16 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 4.70M |
| Total Debt | 872,000 |
| Net Cash | 3.83M |
| Net Cash Per Share | $0.35 |
| Equity (Book Value) | 11.97M |
| Book Value Per Share | 1.10 |
| Working Capital | 10.25M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -661,000 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 126,000 |
| Net Borrowing | -6,000 |
| Free Cash Flow | -661,000 |
| FCF Per Share | -$0.06 |
Margins
| Measure | Value |
|---|
| Gross Margin | 61.26% |
| Operating Margin | 7.92% |
| Pretax Margin | 8.45% |
| Profit Margin | 8.38% |
| EBITDA Margin | 8.53% |
| EBIT Margin | 7.92% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.21% |
| Shareholder Yield | -4.21% |
| Earnings Yield | 4.94% |
| FCF Yield | -1.92% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $6.25 |
| Price Target Difference | 92.90% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 15.68% |
| EPS Growth Forecast (3Y) | 42.75% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -3.3 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |